nodes	percent_of_prediction	percent_of_DWPC	metapath
Promazine—CYP2C19—Gefitinib—lung cancer	0.0733	0.11	CbGbCtD
Promazine—CYP2C19—Teniposide—lung cancer	0.071	0.107	CbGbCtD
Promazine—CYP2C9—Gefitinib—lung cancer	0.0609	0.0916	CbGbCtD
Promazine—CYP2C9—Teniposide—lung cancer	0.0591	0.0888	CbGbCtD
Promazine—CYP1A2—Erlotinib—lung cancer	0.04	0.0601	CbGbCtD
Promazine—CYP3A4—Topotecan—lung cancer	0.0387	0.0582	CbGbCtD
Promazine—CYP3A4—Gefitinib—lung cancer	0.0354	0.0532	CbGbCtD
Promazine—CYP3A4—Teniposide—lung cancer	0.0343	0.0516	CbGbCtD
Promazine—CYP2C9—Paclitaxel—lung cancer	0.033	0.0496	CbGbCtD
Promazine—CYP1A2—Etoposide—lung cancer	0.0289	0.0435	CbGbCtD
Promazine—CYP3A4—Vinorelbine—lung cancer	0.0273	0.041	CbGbCtD
Promazine—CYP2C9—Cisplatin—lung cancer	0.0265	0.0399	CbGbCtD
Promazine—CYP3A4—Crizotinib—lung cancer	0.0217	0.0326	CbGbCtD
Promazine—CYP3A4—Erlotinib—lung cancer	0.0209	0.0315	CbGbCtD
Promazine—CYP3A4—Paclitaxel—lung cancer	0.0192	0.0288	CbGbCtD
Promazine—CYP3A4—Irinotecan—lung cancer	0.0189	0.0284	CbGbCtD
Promazine—CYP3A4—Vinblastine—lung cancer	0.0168	0.0253	CbGbCtD
Promazine—CYP3A4—Etoposide—lung cancer	0.0151	0.0228	CbGbCtD
Promazine—CYP3A4—Docetaxel—lung cancer	0.0139	0.0208	CbGbCtD
Promazine—HTR2A—phrenic nerve—lung cancer	0.0113	0.342	CbGeAlD
Promazine—CYP3A4—Doxorubicin—lung cancer	0.0103	0.0155	CbGbCtD
Promazine—HTR2A—pulmonary artery—lung cancer	0.00412	0.124	CbGeAlD
Promazine—CHRM5—epithelium—lung cancer	0.00174	0.0526	CbGeAlD
Promazine—ADRA1D—epithelium—lung cancer	0.00156	0.047	CbGeAlD
Promazine—CYP2C9—mammary gland—lung cancer	0.00126	0.0381	CbGeAlD
Promazine—DRD2—respiratory system—lung cancer	0.00105	0.0317	CbGeAlD
Promazine—CHRM1—trachea—lung cancer	0.000963	0.0291	CbGeAlD
Promazine—ADRA1A—epithelium—lung cancer	0.000895	0.027	CbGeAlD
Promazine—CYP1A2—respiratory system—lung cancer	0.000886	0.0267	CbGeAlD
Promazine—HRH1—respiratory system—lung cancer	0.000829	0.025	CbGeAlD
Promazine—HRH1—epithelium—lung cancer	0.000693	0.0209	CbGeAlD
Promazine—HTR2A—respiratory system—lung cancer	0.000693	0.0209	CbGeAlD
Promazine—CHRM1—lung—lung cancer	0.000692	0.0209	CbGeAlD
Promazine—ADRA2A—bronchus—lung cancer	0.00067	0.0202	CbGeAlD
Promazine—HRH1—trachea—lung cancer	0.000613	0.0185	CbGeAlD
Promazine—Clomipramine—GSTP1—lung cancer	0.000602	0.0705	CrCbGaD
Promazine—ADRA2A—trachea—lung cancer	0.000602	0.0182	CbGeAlD
Promazine—HTR2A—epithelium—lung cancer	0.000579	0.0175	CbGeAlD
Promazine—ADRA2A—cardiac atrium—lung cancer	0.000565	0.0171	CbGeAlD
Promazine—DRD2—lung—lung cancer	0.000557	0.0168	CbGeAlD
Promazine—HTR2A—trachea—lung cancer	0.000512	0.0154	CbGeAlD
Promazine—CYP1A2—lung—lung cancer	0.00047	0.0142	CbGeAlD
Promazine—HRH1—lung—lung cancer	0.00044	0.0133	CbGeAlD
Promazine—ADRA2A—lung—lung cancer	0.000432	0.0131	CbGeAlD
Promazine—Brompheniramine—CYP2E1—lung cancer	0.000419	0.0491	CrCbGaD
Promazine—Tamoxifen—CYP2A6—lung cancer	0.000383	0.0448	CrCbGaD
Promazine—HTR2A—lung—lung cancer	0.000368	0.0111	CbGeAlD
Promazine—Desipramine—CYP2A6—lung cancer	0.00035	0.041	CrCbGaD
Promazine—Tamoxifen—ABCG2—lung cancer	0.000342	0.0401	CrCbGaD
Promazine—Fluphenazine—CYP2E1—lung cancer	0.000338	0.0396	CrCbGaD
Promazine—HRH1—lymph node—lung cancer	0.000301	0.00909	CbGeAlD
Promazine—ADRA2A—lymph node—lung cancer	0.000296	0.00893	CbGeAlD
Promazine—Oxcarbazepine—ALB—lung cancer	0.000296	0.0346	CrCbGaD
Promazine—Thioridazine—CYP2E1—lung cancer	0.000291	0.0341	CrCbGaD
Promazine—Methotrimeprazine—CYP2E1—lung cancer	0.000278	0.0325	CrCbGaD
Promazine—Tamoxifen—CYP2E1—lung cancer	0.000272	0.0318	CrCbGaD
Promazine—Tamoxifen—CYP1A1—lung cancer	0.000268	0.0314	CrCbGaD
Promazine—Orphenadrine—CYP2E1—lung cancer	0.000264	0.0309	CrCbGaD
Promazine—Diltiazem—ABCB1—lung cancer	0.000258	0.0303	CrCbGaD
Promazine—Desipramine—CYP2E1—lung cancer	0.000249	0.0291	CrCbGaD
Promazine—Triflupromazine—ABCB1—lung cancer	0.00023	0.027	CrCbGaD
Promazine—Acepromazine—ALB—lung cancer	0.000223	0.0261	CrCbGaD
Promazine—Thioproperazine—ALB—lung cancer	0.000218	0.0256	CrCbGaD
Promazine—Pipotiazine—ALB—lung cancer	0.000215	0.0251	CrCbGaD
Promazine—Chlorpromazine—CYP2E1—lung cancer	0.000212	0.0248	CrCbGaD
Promazine—Imipramine—CYP2E1—lung cancer	0.000211	0.0247	CrCbGaD
Promazine—Amitriptyline—CYP2E1—lung cancer	0.00021	0.0245	CrCbGaD
Promazine—Carbamazepine—ABCB1—lung cancer	0.000192	0.0225	CrCbGaD
Promazine—Fluphenazine—ABCB1—lung cancer	0.000177	0.0207	CrCbGaD
Promazine—Clomipramine—ALB—lung cancer	0.00017	0.0199	CrCbGaD
Promazine—Clomipramine—ABCB1—lung cancer	0.000162	0.019	CrCbGaD
Promazine—Chlorprothixene—ABCB1—lung cancer	0.000161	0.0189	CrCbGaD
Promazine—Trimipramine—ABCB1—lung cancer	0.000149	0.0175	CrCbGaD
Promazine—Promethazine—ABCB1—lung cancer	0.000143	0.0168	CrCbGaD
Promazine—Tamoxifen—ABCB1—lung cancer	0.000142	0.0167	CrCbGaD
Promazine—Doxepin—ABCB1—lung cancer	0.000142	0.0166	CrCbGaD
Promazine—Trifluoperazine—ABCB1—lung cancer	0.000142	0.0166	CrCbGaD
Promazine—Quetiapine—ABCB1—lung cancer	0.000137	0.0161	CrCbGaD
Promazine—Desipramine—ABCB1—lung cancer	0.00013	0.0153	CrCbGaD
Promazine—Chlorpromazine—ALB—lung cancer	0.000116	0.0136	CrCbGaD
Promazine—Amitriptyline—ALB—lung cancer	0.000115	0.0135	CrCbGaD
Promazine—Chlorpromazine—ABCB1—lung cancer	0.000111	0.013	CrCbGaD
Promazine—Imipramine—ABCB1—lung cancer	0.000111	0.0129	CrCbGaD
Promazine—Amitriptyline—ABCB1—lung cancer	0.00011	0.0129	CrCbGaD
Promazine—DRD2—Signaling Pathways—CDKN1A—lung cancer	8.94e-06	3.05e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—CCND1—lung cancer	8.92e-06	3.04e-05	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—PTEN—lung cancer	8.92e-06	3.04e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—JUN—lung cancer	8.91e-06	3.04e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—CCND1—lung cancer	8.9e-06	3.04e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—JUN—lung cancer	8.88e-06	3.03e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—CXCL8—lung cancer	8.88e-06	3.03e-05	CbGpPWpGaD
Promazine—CYP2C9—Metabolism—POMC—lung cancer	8.86e-06	3.02e-05	CbGpPWpGaD
Promazine—CYP2C19—Metabolism—ALB—lung cancer	8.86e-06	3.02e-05	CbGpPWpGaD
Promazine—CHRM4—Signaling Pathways—TP53—lung cancer	8.83e-06	3.01e-05	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—MMP9—lung cancer	8.82e-06	3.01e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling by GPCR—HRAS—lung cancer	8.82e-06	3.01e-05	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—MMP9—lung cancer	8.81e-06	3e-05	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—CDKN1A—lung cancer	8.79e-06	3e-05	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—MMP9—lung cancer	8.78e-06	2.99e-05	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—CDKN1A—lung cancer	8.77e-06	2.99e-05	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—PTEN—lung cancer	8.77e-06	2.99e-05	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—CAT—lung cancer	8.76e-06	2.99e-05	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—PTEN—lung cancer	8.75e-06	2.99e-05	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—MMP9—lung cancer	8.75e-06	2.99e-05	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—CDKN1A—lung cancer	8.75e-06	2.98e-05	CbGpPWpGaD
Promazine—CHRM5—Signaling Pathways—PIK3CA—lung cancer	8.74e-06	2.98e-05	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—VEGFA—lung cancer	8.73e-06	2.98e-05	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—PTEN—lung cancer	8.73e-06	2.98e-05	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—CDKN1A—lung cancer	8.72e-06	2.97e-05	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—APOA1—lung cancer	8.72e-06	2.97e-05	CbGpPWpGaD
Promazine—DRD2—Signaling by GPCR—AKT1—lung cancer	8.7e-06	2.97e-05	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—PTEN—lung cancer	8.7e-06	2.97e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—MMP9—lung cancer	8.66e-06	2.96e-05	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—STAT3—lung cancer	8.65e-06	2.95e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—MMP9—lung cancer	8.64e-06	2.95e-05	CbGpPWpGaD
Promazine—CYP2C9—Metabolism—CREBBP—lung cancer	8.63e-06	2.95e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—CDKN1A—lung cancer	8.63e-06	2.95e-05	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—MAPK3—lung cancer	8.63e-06	2.95e-05	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—NRAS—lung cancer	8.63e-06	2.94e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—PTEN—lung cancer	8.61e-06	2.94e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—CDKN1A—lung cancer	8.61e-06	2.94e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—PTEN—lung cancer	8.59e-06	2.93e-05	CbGpPWpGaD
Promazine—ADRA2A—GPCR downstream signaling—AKT1—lung cancer	8.57e-06	2.93e-05	CbGpPWpGaD
Promazine—DRD4—Signaling Pathways—HRAS—lung cancer	8.56e-06	2.92e-05	CbGpPWpGaD
Promazine—HTR2A—Signaling by GPCR—AKT1—lung cancer	8.56e-06	2.92e-05	CbGpPWpGaD
Promazine—HRH1—Signaling by GPCR—AKT1—lung cancer	8.54e-06	2.91e-05	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—ABCB1—lung cancer	8.52e-06	2.91e-05	CbGpPWpGaD
Promazine—CHRM1—Signaling by GPCR—AKT1—lung cancer	8.51e-06	2.9e-05	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—EP300—lung cancer	8.5e-06	2.9e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—CASP3—lung cancer	8.5e-06	2.9e-05	CbGpPWpGaD
Promazine—CHRM3—Signaling by GPCR—AKT1—lung cancer	8.49e-06	2.9e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—IL2—lung cancer	8.48e-06	2.89e-05	CbGpPWpGaD
Promazine—CHRM5—Signaling Pathways—TP53—lung cancer	8.46e-06	2.89e-05	CbGpPWpGaD
Promazine—CHRM4—Signaling Pathways—HRAS—lung cancer	8.45e-06	2.88e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling by GPCR—IL6—lung cancer	8.44e-06	2.88e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling by GPCR—AKT1—lung cancer	8.4e-06	2.87e-05	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—MYC—lung cancer	8.4e-06	2.86e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling by GPCR—AKT1—lung cancer	8.38e-06	2.86e-05	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—TYMS—lung cancer	8.37e-06	2.85e-05	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—EP300—lung cancer	8.37e-06	2.85e-05	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—EP300—lung cancer	8.35e-06	2.85e-05	CbGpPWpGaD
Promazine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	8.35e-06	2.85e-05	CbGpPWpGaD
Promazine—DRD1—Signaling Pathways—PIK3CA—lung cancer	8.33e-06	2.84e-05	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—EP300—lung cancer	8.32e-06	2.84e-05	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—EP300—lung cancer	8.29e-06	2.83e-05	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—GSTM1—lung cancer	8.27e-06	2.82e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—CCND1—lung cancer	8.27e-06	2.82e-05	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—SRC—lung cancer	8.27e-06	2.82e-05	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—MAPK3—lung cancer	8.26e-06	2.82e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—JUN—lung cancer	8.25e-06	2.82e-05	CbGpPWpGaD
Promazine—ADRA1D—Signaling Pathways—PIK3CA—lung cancer	8.22e-06	2.8e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—EP300—lung cancer	8.21e-06	2.8e-05	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—EGFR—lung cancer	8.21e-06	2.8e-05	CbGpPWpGaD
Promazine—DRD4—Signaling Pathways—IL6—lung cancer	8.19e-06	2.8e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—EP300—lung cancer	8.19e-06	2.79e-05	CbGpPWpGaD
Promazine—CYP2C9—Metabolism—PIK3CD—lung cancer	8.19e-06	2.79e-05	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—SRC—lung cancer	8.14e-06	2.78e-05	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—SRC—lung cancer	8.12e-06	2.77e-05	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—SRC—lung cancer	8.09e-06	2.76e-05	CbGpPWpGaD
Promazine—CHRM5—Signaling Pathways—HRAS—lung cancer	8.09e-06	2.76e-05	CbGpPWpGaD
Promazine—CHRM4—Signaling Pathways—IL6—lung cancer	8.08e-06	2.76e-05	CbGpPWpGaD
Promazine—CYP2C9—Metabolism—ALB—lung cancer	8.08e-06	2.76e-05	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—SRC—lung cancer	8.07e-06	2.75e-05	CbGpPWpGaD
Promazine—DRD1—Signaling Pathways—TP53—lung cancer	8.06e-06	2.75e-05	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—VEGFA—lung cancer	8.05e-06	2.75e-05	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—MYC—lung cancer	8.04e-06	2.74e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—MMP9—lung cancer	8.03e-06	2.74e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—CDKN1A—lung cancer	8e-06	2.73e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—SRC—lung cancer	7.99e-06	2.73e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—PTEN—lung cancer	7.98e-06	2.72e-05	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—STAT3—lung cancer	7.97e-06	2.72e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—SRC—lung cancer	7.97e-06	2.72e-05	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—PIK3CG—lung cancer	7.96e-06	2.72e-05	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—NRAS—lung cancer	7.95e-06	2.71e-05	CbGpPWpGaD
Promazine—ADRA1D—Signaling Pathways—TP53—lung cancer	7.95e-06	2.71e-05	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—VEGFA—lung cancer	7.92e-06	2.7e-05	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—VEGFA—lung cancer	7.91e-06	2.7e-05	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—VEGFA—lung cancer	7.88e-06	2.69e-05	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—EGFR—lung cancer	7.86e-06	2.68e-05	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—VEGFA—lung cancer	7.86e-06	2.68e-05	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—STAT3—lung cancer	7.85e-06	2.68e-05	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—CYP1A1—lung cancer	7.84e-06	2.68e-05	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—STAT3—lung cancer	7.83e-06	2.67e-05	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—NRAS—lung cancer	7.83e-06	2.67e-05	CbGpPWpGaD
Promazine—CYP2C19—Metabolism—PIK3CB—lung cancer	7.83e-06	2.67e-05	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—NRAS—lung cancer	7.81e-06	2.66e-05	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—STAT3—lung cancer	7.8e-06	2.66e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling by GPCR—AKT1—lung cancer	7.79e-06	2.66e-05	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—NRAS—lung cancer	7.78e-06	2.66e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—VEGFA—lung cancer	7.78e-06	2.65e-05	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—STAT3—lung cancer	7.78e-06	2.65e-05	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—ERCC2—lung cancer	7.78e-06	2.65e-05	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—NRAS—lung cancer	7.76e-06	2.65e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—VEGFA—lung cancer	7.76e-06	2.65e-05	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—KRAS—lung cancer	7.76e-06	2.65e-05	CbGpPWpGaD
Promazine—CYP2C19—Metabolism—PTGS2—lung cancer	7.75e-06	2.65e-05	CbGpPWpGaD
Promazine—CHRM5—Signaling Pathways—IL6—lung cancer	7.74e-06	2.64e-05	CbGpPWpGaD
Promazine—DRD1—Signaling Pathways—HRAS—lung cancer	7.71e-06	2.63e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—STAT3—lung cancer	7.7e-06	2.63e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—NRAS—lung cancer	7.68e-06	2.62e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—STAT3—lung cancer	7.68e-06	2.62e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—NRAS—lung cancer	7.66e-06	2.61e-05	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—MAPK3—lung cancer	7.62e-06	2.6e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—EP300—lung cancer	7.61e-06	2.6e-05	CbGpPWpGaD
Promazine—ADRA1D—Signaling Pathways—HRAS—lung cancer	7.6e-06	2.59e-05	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—POMC—lung cancer	7.57e-06	2.58e-05	CbGpPWpGaD
Promazine—DRD4—Signaling Pathways—AKT1—lung cancer	7.56e-06	2.58e-05	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—MAPK3—lung cancer	7.5e-06	2.56e-05	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—MAPK3—lung cancer	7.48e-06	2.55e-05	CbGpPWpGaD
Promazine—CHRM4—Signaling Pathways—AKT1—lung cancer	7.46e-06	2.54e-05	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—MAPK3—lung cancer	7.46e-06	2.54e-05	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—MAPK3—lung cancer	7.43e-06	2.54e-05	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—KRAS—lung cancer	7.43e-06	2.53e-05	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—MYC—lung cancer	7.41e-06	2.53e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—SRC—lung cancer	7.4e-06	2.53e-05	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—CREBBP—lung cancer	7.38e-06	2.52e-05	CbGpPWpGaD
Promazine—DRD1—Signaling Pathways—IL6—lung cancer	7.38e-06	2.52e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—MAPK3—lung cancer	7.36e-06	2.51e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—MAPK3—lung cancer	7.34e-06	2.5e-05	CbGpPWpGaD
Promazine—CHRM3—Metabolism—PIK3CA—lung cancer	7.34e-06	2.5e-05	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—MYC—lung cancer	7.29e-06	2.49e-05	CbGpPWpGaD
Promazine—ADRA1D—Signaling Pathways—IL6—lung cancer	7.28e-06	2.48e-05	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—MYC—lung cancer	7.27e-06	2.48e-05	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—MYC—lung cancer	7.25e-06	2.47e-05	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—EGFR—lung cancer	7.25e-06	2.47e-05	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—MYC—lung cancer	7.23e-06	2.47e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—VEGFA—lung cancer	7.21e-06	2.46e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—MYC—lung cancer	7.16e-06	2.44e-05	CbGpPWpGaD
Promazine—CHRM5—Signaling Pathways—AKT1—lung cancer	7.14e-06	2.44e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—MYC—lung cancer	7.14e-06	2.44e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—STAT3—lung cancer	7.14e-06	2.44e-05	CbGpPWpGaD
Promazine—CYP2C9—Metabolism—PIK3CB—lung cancer	7.14e-06	2.43e-05	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—EGFR—lung cancer	7.13e-06	2.43e-05	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—PIK3CA—lung cancer	7.13e-06	2.43e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—NRAS—lung cancer	7.12e-06	2.43e-05	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—EGFR—lung cancer	7.12e-06	2.43e-05	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—EGFR—lung cancer	7.09e-06	2.42e-05	CbGpPWpGaD
Promazine—CYP2C9—Metabolism—PTGS2—lung cancer	7.07e-06	2.41e-05	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—EGFR—lung cancer	7.07e-06	2.41e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—EGFR—lung cancer	7e-06	2.39e-05	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—PIK3CD—lung cancer	7e-06	2.39e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—EGFR—lung cancer	6.98e-06	2.38e-05	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—ALB—lung cancer	6.91e-06	2.36e-05	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—TP53—lung cancer	6.89e-06	2.35e-05	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—KRAS—lung cancer	6.85e-06	2.34e-05	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—PIK3CA—lung cancer	6.82e-06	2.33e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—MAPK3—lung cancer	6.82e-06	2.33e-05	CbGpPWpGaD
Promazine—DRD1—Signaling Pathways—AKT1—lung cancer	6.81e-06	2.32e-05	CbGpPWpGaD
Promazine—CYP2C19—Metabolism—PTEN—lung cancer	6.76e-06	2.31e-05	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—KRAS—lung cancer	6.74e-06	2.3e-05	CbGpPWpGaD
Promazine—ADRA2A—Metabolism—PIK3CA—lung cancer	6.73e-06	2.3e-05	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—APOA1—lung cancer	6.73e-06	2.3e-05	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—KRAS—lung cancer	6.72e-06	2.29e-05	CbGpPWpGaD
Promazine—ADRA1D—Signaling Pathways—AKT1—lung cancer	6.71e-06	2.29e-05	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—KRAS—lung cancer	6.7e-06	2.29e-05	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—KRAS—lung cancer	6.68e-06	2.28e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—MYC—lung cancer	6.63e-06	2.26e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—KRAS—lung cancer	6.61e-06	2.26e-05	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—TP53—lung cancer	6.6e-06	2.25e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—KRAS—lung cancer	6.6e-06	2.25e-05	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—HRAS—lung cancer	6.59e-06	2.25e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—EGFR—lung cancer	6.49e-06	2.21e-05	CbGpPWpGaD
Promazine—CYP2C19—Metabolism—EP300—lung cancer	6.45e-06	2.2e-05	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—HRAS—lung cancer	6.31e-06	2.15e-05	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—IL6—lung cancer	6.31e-06	2.15e-05	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—PIK3CA—lung cancer	6.29e-06	2.15e-05	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—PIK3CA—lung cancer	6.19e-06	2.11e-05	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—PIK3CA—lung cancer	6.18e-06	2.11e-05	CbGpPWpGaD
Promazine—CYP2C9—Metabolism—PTEN—lung cancer	6.17e-06	2.1e-05	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—PIK3CA—lung cancer	6.16e-06	2.1e-05	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—PIK3CG—lung cancer	6.14e-06	2.1e-05	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—PIK3CA—lung cancer	6.14e-06	2.09e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—KRAS—lung cancer	6.13e-06	2.09e-05	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—PIK3CB—lung cancer	6.1e-06	2.08e-05	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—TP53—lung cancer	6.08e-06	2.08e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—PIK3CA—lung cancer	6.08e-06	2.07e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—PIK3CA—lung cancer	6.06e-06	2.07e-05	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—PTGS2—lung cancer	6.04e-06	2.06e-05	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—IL6—lung cancer	6.04e-06	2.06e-05	CbGpPWpGaD
Promazine—CHRM3—Metabolism—AKT1—lung cancer	5.99e-06	2.05e-05	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—TP53—lung cancer	5.99e-06	2.04e-05	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—TP53—lung cancer	5.97e-06	2.04e-05	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—TP53—lung cancer	5.95e-06	2.03e-05	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—TP53—lung cancer	5.94e-06	2.03e-05	CbGpPWpGaD
Promazine—CYP2C9—Metabolism—EP300—lung cancer	5.88e-06	2.01e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—TP53—lung cancer	5.88e-06	2.01e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—TP53—lung cancer	5.86e-06	2e-05	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—POMC—lung cancer	5.85e-06	1.99e-05	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—AKT1—lung cancer	5.82e-06	1.99e-05	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—HRAS—lung cancer	5.82e-06	1.99e-05	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—HRAS—lung cancer	5.73e-06	1.95e-05	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—HRAS—lung cancer	5.71e-06	1.95e-05	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—HRAS—lung cancer	5.7e-06	1.94e-05	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—CREBBP—lung cancer	5.69e-06	1.94e-05	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—HRAS—lung cancer	5.68e-06	1.94e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—PIK3CA—lung cancer	5.63e-06	1.92e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—HRAS—lung cancer	5.62e-06	1.92e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—HRAS—lung cancer	5.61e-06	1.91e-05	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—AKT1—lung cancer	5.57e-06	1.9e-05	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—IL6—lung cancer	5.57e-06	1.9e-05	CbGpPWpGaD
Promazine—ADRA2A—Metabolism—AKT1—lung cancer	5.5e-06	1.88e-05	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—IL6—lung cancer	5.48e-06	1.87e-05	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—IL6—lung cancer	5.47e-06	1.87e-05	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—IL6—lung cancer	5.45e-06	1.86e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—TP53—lung cancer	5.45e-06	1.86e-05	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—IL6—lung cancer	5.43e-06	1.85e-05	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—PIK3CD—lung cancer	5.4e-06	1.84e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—IL6—lung cancer	5.38e-06	1.84e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—IL6—lung cancer	5.37e-06	1.83e-05	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—ALB—lung cancer	5.33e-06	1.82e-05	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—PTEN—lung cancer	5.27e-06	1.8e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—HRAS—lung cancer	5.21e-06	1.78e-05	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—AKT1—lung cancer	5.14e-06	1.75e-05	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—AKT1—lung cancer	5.06e-06	1.72e-05	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—AKT1—lung cancer	5.04e-06	1.72e-05	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—AKT1—lung cancer	5.03e-06	1.72e-05	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—EP300—lung cancer	5.02e-06	1.71e-05	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—AKT1—lung cancer	5.01e-06	1.71e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—IL6—lung cancer	4.99e-06	1.7e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—AKT1—lung cancer	4.96e-06	1.69e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—AKT1—lung cancer	4.95e-06	1.69e-05	CbGpPWpGaD
Promazine—CYP2C19—Metabolism—PIK3CA—lung cancer	4.77e-06	1.63e-05	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—PIK3CB—lung cancer	4.71e-06	1.61e-05	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—PTGS2—lung cancer	4.66e-06	1.59e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—AKT1—lung cancer	4.6e-06	1.57e-05	CbGpPWpGaD
Promazine—CYP2C9—Metabolism—PIK3CA—lung cancer	4.35e-06	1.48e-05	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—PTEN—lung cancer	4.07e-06	1.39e-05	CbGpPWpGaD
Promazine—CYP2C19—Metabolism—AKT1—lung cancer	3.9e-06	1.33e-05	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—EP300—lung cancer	3.88e-06	1.32e-05	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—PIK3CA—lung cancer	3.72e-06	1.27e-05	CbGpPWpGaD
Promazine—CYP2C9—Metabolism—AKT1—lung cancer	3.55e-06	1.21e-05	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—AKT1—lung cancer	3.04e-06	1.04e-05	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—PIK3CA—lung cancer	2.87e-06	9.79e-06	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—AKT1—lung cancer	2.34e-06	8e-06	CbGpPWpGaD
